Healthcare provider profile · identity verified

Diane L Kennedy, M.D.

Family Practice · LUVERNE, MN · NPI 1316939721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	547	142
Levothyroxine Sodium	Levothyroxine Sodium	444	103
Amlodipine Besylate	Amlodipine Besylate	366	80
Lisinopril	Lisinopril	348	82
Metoprolol Succinate	Metoprolol Succinate	336	76
Omeprazole	Omeprazole	335	90
Furosemide	Furosemide	329	69
Gabapentin	Gabapentin	308	58
Sertraline Hcl	Sertraline Hcl	287	55
Eliquis	Apixaban	236	32
Metoprolol Tartrate	Metoprolol Tartrate	232	49
Potassium Chloride	Potassium Chloride	230	47
Rosuvastatin Calcium	Rosuvastatin Calcium	206	63
Memantine Hcl	Memantine Hcl	199	26
Spironolactone	Spironolactone	192	44
Jardiance	Empagliflozin	189	23
Losartan Potassium	Losartan Potassium	179	42
Hydrochlorothiazide	Hydrochlorothiazide	176	47
Metformin Hcl Er	Metformin Hcl	160	43
Tramadol Hcl	Tramadol Hcl	159	66
Escitalopram Oxalate	Escitalopram Oxalate	153	36
Duloxetine Hcl	Duloxetine Hcl	147	31
Simvastatin	Simvastatin	146	41
Mirtazapine	Mirtazapine	139	34
Tamsulosin Hcl	Tamsulosin Hcl	130	44
Pantoprazole Sodium	Pantoprazole Sodium	125	35
Allopurinol	Allopurinol	118	26
Famotidine	Famotidine	118	27
Metformin Hcl	Metformin Hcl	113	20
Xarelto	Rivaroxaban	106	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	99	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	94	20
Oxycodone Hcl	Oxycodone Hcl	94	25
Clopidogrel	Clopidogrel Bisulfate	93	18
Pravastatin Sodium	Pravastatin Sodium	89	18
Jantoven	Warfarin Sodium	86	15
Lorazepam	Lorazepam	83	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	30
Prednisone	Prednisone	80	42
Olmesartan Medoxomil	Olmesartan Medoxomil	78	22
Donepezil Hcl	Donepezil Hcl	76	suppressed
Celecoxib	Celecoxib	73	19
Ropinirole Hcl	Ropinirole Hcl	72	12
Bupropion Xl	Bupropion Hcl	68	23
Clonazepam	Clonazepam	66	24
Fluoxetine Hcl	Fluoxetine Hcl	66	18
Pregabalin	Pregabalin	66	12
Cephalexin	Cephalexin	65	31
Fluticasone Propionate	Fluticasone Propionate	65	23
Myrbetriq	Mirabegron	61	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	13
Albuterol Sulfate Hfa	Albuterol Sulfate	57	22
Triamcinolone Acetonide	Triamcinolone Acetonide	57	36
Breo Ellipta	Fluticasone/Vilanterol	56	suppressed
Carvedilol	Carvedilol	55	11
Ozempic	Semaglutide	53	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	19
Estradiol	Estradiol	52	24
Valsartan	Valsartan	52	11
Paroxetine Hcl	Paroxetine Hcl	47	11
Divalproex Sodium	Divalproex Sodium	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Warfarin Sodium	Warfarin Sodium	46	13
Alendronate Sodium	Alendronate Sodium	44	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Latanoprost	Latanoprost	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	13
Meloxicam	Meloxicam	41	16
Naproxen	Naproxen	41	12
Methenamine Hippurate	Methenamine Hippurate	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	12
Trazodone Hcl	Trazodone Hcl	38	13
Digoxin	Digoxin	37	suppressed
Finasteride	Finasteride	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Spiriva Respimat	Tiotropium Bromide	37	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	11
Aripiprazole	Aripiprazole	34	suppressed
Atenolol	Atenolol	34	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Cefuroxime	Cefuroxime Axetil	33	32
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	12
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Alprazolam	Alprazolam	29	12
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	13
Temazepam	Temazepam	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Fentanyl	Fentanyl	24	suppressed
Risperidone	Risperidone	24	suppressed
Amoxicillin	Amoxicillin	23	23
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ondansetron Odt	Ondansetron	22	12
Doxycycline Hyclate	Doxycycline Hyclate	21	16
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	20	11
Baclofen	Baclofen	19	suppressed
Calcitriol	Calcitriol	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Azithromycin	Azithromycin	17	17
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Cartia Xt	Diltiazem Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Sure Comfort Alcohol	Alcohol Antiseptic Pads	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Budesonide Ec	Budesonide	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Nystatin	Nystatin	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Torsemide	Torsemide	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error